[STOK] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[STOK] Stoke Therapeutics, Inc.
Announcement Date
08-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -2.87%
YoY- -65.13%
Quarter Report
STOK's Result
STOK's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 3,231 3,000 0 0 0 0 0 -
PBT -24,652 -24,649 -24,448 -22,597 -21,967 -16,793 -14,561 42.18%
Tax -1,432 -250 -78 -44 -34 -254 -10 2662.12%
NP -23,220 -24,399 -24,448 -22,597 -21,967 -16,793 -14,561 36.61%
Tax Rate - - - - - - - -
Total Cost 26,451 27,399 24,448 22,597 21,967 16,793 14,561 49.04%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -718.66 -813.30 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.59 -0.65 -0.66 -0.61 -0.60 -0.46 -0.44 21.66%
EPS Diluted -0.59 -0.65 -0.66 -0.61 -0.60 -0.46 -0.44 21.66%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.